BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8056523)

  • 1. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG; Brem RB; Wilson DJ; O'Rourke LM; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M; Esser P; Heimann K; Wiedemann P
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localisation of opticin in human proliferative retinal disease.
    Pattwell DM; Sheridan CM; Le Goff M; Bishop PN; Hiscott P
    Exp Eye Res; 2010 Mar; 90(3):461-4. PubMed ID: 20036236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M; Esser P; Wiedemann P; Heimann K
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
    Kauffmann DJ; van Meurs JC; Mertens DA; Peperkamp E; Master C; Gerritsen ME
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):900-6. PubMed ID: 8125753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
    Gendron RL; Good WV; Adams LC; Paradis H
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases.
    Heidenkummer HP; Kampik A; Petrovski B
    Retina; 1992; 12(1):52-8. PubMed ID: 1565872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors.
    Droz D; Patey N; Paraf F; Chrétien Y; Gogusev J
    Lab Invest; 1994 Nov; 71(5):710-8. PubMed ID: 7526040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1991; 88(4):337-40. PubMed ID: 1786916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP; Kampik A
    Fortschr Ophthalmol; 1991; 88(3):219-24. PubMed ID: 1889766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Augustin AJ; Spitznas M; Koch F; Grus F; Böker T
    Ger J Ophthalmol; 1995 Jan; 4(1):47-51. PubMed ID: 7728110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy.
    Casaroli Marano RP; Vilaró S
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2791-803. PubMed ID: 7514582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
    Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
    Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
    Heidenkummer HP; Kampik A
    Ger J Ophthalmol; 1992; 1(3-4):170-5. PubMed ID: 1483131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.